{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Investigating the effects of mutations on PINK1 kinase activity in vitro and on expression levels and localization in mammalian cells",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper discusses the effects of mutations in PINK1 gene associated with recessive parkinsonism. The encoded protein is predicted to be a Ser/Thr protein kinase targeted to mitochondria.",
          "judgment": "Yes",
          "reasoning": "The paper provides clear statements about the function of the PINK1 protein and its role in parkinsonism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses kinase activity, expression levels, and localization assays in vitro and mammalian cells.",
          "judgment": "Yes",
          "reasoning": "Assays like kinase activity, protein expression, and cellular localization are commonly used to study the effects of mutations on proteins, which aligns with the disease pathogenesis."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "sub_step_name": "3a. Basic Controls and Replicates",
              "sub_questions": [
                {
                  "question": "Were basic controls included for this assay?",
                  "answer": "Yes"
                },
                {
                  "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                  "answer": "No information provided"
                }
              ],
              "judgment": "Partial"
            },
            {
              "sub_step_name": "3b. Accepted/Validated Assay",
              "question": "Has the specific instance of the assay been: a) Broadly accepted historically? OR b) Previously validated in other studies (cited)? OR c) Provided as a commercial kit with defined performance metrics, but where controls/replicates are not documented for the specific instance of the assay in this paper?",
              "answer": "Not applicable"
            },
            {
              "sub_step_name": "3c. Variant Controls",
              "question": "Were variant controls used in the assay for this variant?",
              "answer": "No information provided"
            }
          ]
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_steps": [
            {
              "sub_step_name": "4a. Statistical Analyses",
              "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
              "answer": "No information provided"
            },
            {
              "sub_step_name": "4b. No OddsPath Calculation (if statistical analyses were insufficient)",
              "question": "How many total benign/pathogenic variant controls were used across the entire study?",
              "answer": "Not applicable"
            }
          ]
        }
      ]
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": " ",
          "alt": " ",
          "position": "not provided"
        },
        "variant_string_id": "Not applicable"
      },
      "functional_evidence_aim": "Not applicable",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper discusses the effects of mutations in PINK1 gene associated with recessive parkinsonism. The encoded protein is predicted to be a Ser/Thr protein kinase targeted to mitochondria.",
          "judgment": "Yes",
          "reasoning": "The paper provides clear statements about the function of the PINK1 protein and its role in parkinsonism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses protein stability, ATP-binding, and kinase activity assays.",
          "judgment": "Yes",
          "reasoning": "Assays like protein stability, ATP-binding, and kinase activity are commonly used to study the effects of mutations on proteins, which aligns with the disease pathogenesis."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "sub_step_name": "3a. Basic Controls and Replicates",
              "sub_questions": [
                {
                  "question": "Were basic controls included for this assay?",
                  "answer": "Yes"
                },
                {
                  "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                  "answer": "No information provided"
                }
              ],
              "judgment": "Partial"
            },
            {
              "sub_step_name": "3b. Accepted/Validated Assay",
              "question": "Has the specific instance of the assay been: a) Broadly accepted historically? OR b) Previously validated in other studies (cited)? OR c) Provided as a commercial kit with defined performance metrics, but where controls/replicates are not documented for the specific instance of the assay in this paper?",
              "answer": "Not applicable"
            },
            {
              "sub_step_name": "3c. Variant Controls",
              "question": "Were variant controls used in the assay for this variant?",
              "answer": "No information provided"
            }
          ]
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_steps": [
            {
              "sub_step_name": "4a. Statistical Analyses",
              "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
              "answer": "No information provided"
            },
            {
              "sub_step_name": "4b. No OddsPath Calculation (if statistical analyses were insufficient)",
              "question": "How many total benign/pathogenic variant controls were used across the entire study?",
              "answer": "Not applicable"
            }
          ]
        }
      ]
    }
  ]
}